The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, Angelica, Campagnoli, Lucrezia Irene Maria, Fahmideh, Foroogh, Pierella, Elisa, Romeo, Marcello, Ricevuti, Giovanni, Nicoletta, Marchesi, Chirumbolo, Salvatore +1 more·2022·International Journal of Molecular Sciences

DOI 10.3390/ijms232012289

Cites (518)

Items 401–519 of 519

Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
Xiaoyan Yang, Peng Feng, Rong Ji, Yiqing Ren, Wenshi Wei, Christian Hölscher · 2022 · Expert Opinion on Therapeutic Targets
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status
Voigt, Robin M., Wang, Zeneng, Brown, J. Mark, Engen, Phillip A., Naqib, Ankur, Goetz, Christopher G., Hall, Deborah A., Metman, Leo Verhagen, Shaikh, Maliha, Forsyth, Christopher B. et al. · 2022 · Neurobiology of Disease
Total, insoluble, and soluble dietary fiber intake and insulin resistance and blood pressure in adolescents
Yutong Dong, Li Chen, Bernard Gutin, Haidong Zhu · 2018 · European Journal of Clinical Nutrition
Oral Factors That Impact the Oral Microbiota in Parkinson’s Disease
Natalia S. Rozas, Gena DeVue Tribble, Cameron B. Jeter · 2021 · Microorganisms
A new validated HPLC method for the determination of levodopa: Application to study the impact of ketogenic diet on the pharmacokinetics of levodopa in Parkinson's participants
Fawzy Elbarbry, Van Nguyen, Alar Mirka, Heather L. Zwickey, Richard Rosenbaum · 2018 · Biomedical Chromatography
1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis
Zhu, Yuanhui, Huan, Fei, Wang, Junfeng, Xie, Xuexue, Yu, Guoqin, Wang, Xi, Jiang, Lei, Gao, Rong, Xiao, Hang, Ding, Haixia et al. · 2020 · ACS Chemical Neuroscience
Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
Sarah Vascellari, Marta Melis, Vanessa Palmas, Silvia Pisanu, Alessandra Serra, Daniela Perra, Maria Laura Santoru, Valentina Oppo, Roberto Cusano, Paolo Uva et al. · 2021 · Biomolecules
Rifampicin Attenuates the MPTP-Induced Neurotoxicity in Mouse Brain
Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H., Hara, H. · 2006 · Brain Research
Rifampicin and Parkinson’s disease
Wei Bi, Lihong Zhu, Xiuna Jing, Yanran Liang, Enxiang Tao · 2012 · Neurological Sciences
Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson's disease
Ostendorf, Friederike, Metzdorf, Judith, Gold, Ralf, Haghikia, Aiden, Tönges, Lars · 2020 · Molecules
An Alternative Explanation for Alzheimer’s Disease and Parkinson’s Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins
Kevin Roe · 2021 · Neurochemical Research
Minocycline prevents paraquat-induced cell death through attenuating endoplasmic reticulum stress and mitochondrial dysfunction
Chuen‐Lin Huang, Yi‐Chao Lee, Ying-Chen Yang, Tsun-Yung Kuo, Nai‐Kuei Huang · 2012 · Toxicology Letters
Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson’s disease
Handan Koyuncu, Vural Fidan, Hayal Ergin Toktaş, Omer Binay, Hamit Çelik · 2020 · Acta Neurologica Belgica
Association of Parkinson’s Disease With Microbes and Microbiological Therapy
Chen, Zhao-Ji, Liang, Cheng-Yu, Yang, Li-Qing, Ren, Si-Min, Xia, Yan-Min, Cui, Lei, Li, Xiao-Fang, Gao, Bu-Lang · 2021 · Frontiers in Cellular and Infection Microbiology
Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut
Cui, Chun, Hong, Hui, Shi, Yun, Zhou, Yu, Qiao, Chen-Meng, Zhao, Wei-Jiang, Zhao, Li-Ping, Wu, Jian, Quan, Wei, Niu, Gu-Yu et al. · 2023 · Journal of Neuroimmune Pharmacology
The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders
Urdhva Raval, Joyce M. Harary, Emma Zeng, Giulio Maria Pasinetti · 2020 · Expert Review of Neurotherapeutics
Cross-Sectional Study on the Gut Microbiome of Parkinson’s Disease Patients in Central China
Liangwei Mao, Yu Zhang, Jing Tian, Ming Sang, Guimin Zhang, Yuling Zhou, Puqing Wang · 2021 · Frontiers in Microbiology
Differences in the Composition of Gut Microbiota between Patients with Parkinson’s Disease and Healthy Controls: A Cohort Study
Zapała, Barbara, Stefura, Tomasz, Wójcik-Pędziwiatr, Magdalena, Kabut, Radosław, Bałajewicz-Nowak, Marta, Milewicz, Tomasz, Dudek, Alicja, Stój, Anastazja, Rudzińska-Bar, Monika · 2021 · Journal of Clinical Medicine
Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro
Marta Gallardo-Fernández, Ruth Hornedo Ortega, Isabel María Alonso-Bellido, José A. Rodríguez‐Gómez, Ana Maria Troncoso, María Carmen García-Parrilla, Jose Luis Venero, Ana M. Espinosa‐Oliva, Rocío M. de Pablos · 2019 · Antioxidants
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease
Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Jean Yee Hwa Yang, Carolyn M. Sue, Ryan L. Davis · 2021 · Journal of Neurology
Diet Quality and Risk of Parkinson’s Disease: The Rotterdam Study
Anne J. Strikwerda, Lisanne J. Dommershuijsen, M. Kamran Ikram, Trudy Voortman · 2021 · Nutrients
The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems
Mahdieh Rahmani, Sofı́a Negro, Emilia Barcia · 2022 · European Journal of Pharmaceutical Sciences
Exploring Human-Genome Gut-Microbiome Interaction in Parkinson’s Disease
Wallen, Zachary D., Stone, William J., Factor, Stewart A., Molho, Eric, Zabetian, Cyrus P., Standaert, David G., Payami, Haydeh · 2021 · npj Parkinson s Disease
Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
van Kessel, Sebastiaan P., Bullock, Amber, van Dijk, Gertjan, El Aidy, Sahar · 2022 · mSystems
Fecal transplantation for ulcerative colitis: current evidence and future applications
Loris Riccardo Lopetuso, Gianluca Ianiro, Jessica Ravikoff Allegretti, Stefano Bibbò, Antonio Gasbarrini, Franco Scaldaferri, Giovanni Cammarota · 2020 · Expert Opinion on Biological Therapy
The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson’s disease
Zach Dwyer, Melany Chaiquin, Jeffrey Landrigan, Kiara Ayoub, Pragya Shail, Julianna Rocha, Christine L. Childers, Kenneth B. Storey, Dana J. Philpott, Hongyu Sun et al. · 2021 · Journal of Neuroinflammation
Neuroprotective Effects of Heat-Killed Lactobacillus plantarum 200655 Isolated from Kimchi Against Oxidative Stress
Min-Jeong Cheon, Na‐Kyoung Lee, Hyun‐Dong Paik · 2021 · Probiotics and Antimicrobial Proteins
Neuroaspis PLP10™, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson’s disease: A randomized, double-blind, placebo-controlled trial
Marios Pantzaris, G.N. Loukaides, Dimitrios N. Paraskevis, Evangelia Georgia Kostaki, Ioannis S. Patrikios · 2021 · Clinical Neurology and Neurosurgery
Multiomics Implicate Gut Microbiota in Altered Lipid and Energy Metabolism in Parkinson’s Disease
Pereira, Pedro A. B., Trivedi, Drupad K., Silverman, Justin, Duru, Ilhan Cem, Paulin, Lars, Auvinen, Petri, Scheperjans, Filip · 2022 · npj Parkinson s Disease
Ceftriaxone Protects Astrocytes from MPP+ via Suppression of NF-ΚB/JNK/c-Jun Signaling
Zhang, Yunlong, Zhang, Xiuping, Qu, Shaogang · 2015 · Molecular Neurobiology
Ceftriaxone Prevents the Neurodegeneration and Decreased Neurogenesis Seen in a Parkinson’s Disease Rat Model: An Immunohistochemical and MRI Study
Weng, Jun-Cheng, Tikhonova, Maria A., Chen, Jian-Horng, Shen, Mei-Shiuan, Meng, Wan-Yun, Chang, Yen-Ting, Chen, Ke-Hsin, Liang, Keng-Chen, Hung, Ching-Sui, Amstislavskaya, Tamara G. et al. · 2016 · Behavioural Brain Research
Rifampicin Decreases Neuroinflammation to Maintain Mitochondrial Function and Calcium Homeostasis in Rotenone-Treated Zebrafish
Yurtsever, İlknur, Üstündağ, Ünsal Veli, Ünal, İsmail, Ateş, Perihan Seda, Emekli-Alturfan, Ebru · 2022 · Drug and Chemical Toxicology
Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models
Yunfang Su, Ningning Liu, Zijuan Zhang, Hao Li, Jinlian Ma, Ye Yuan, Ming Shi, Jihong Liu, Zhenrong Zhao, Zhenqiang Zhang et al. · 2022 · European Journal of Pharmacology
Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate
Carmen Avagliano, Lorena Coretti, Adriano Lama, Claudio Pirozzi, Carmen De Caro, Davide De Biase, Luigia Turco, Maria Pina Mollica, Orlando Paciello, Antonio Calignano et al. · 2022 · International Journal of Molecular Sciences
Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2α-ATF4 Pathway
Jing, Xiuna, Shi, Qiaoyun, Bi, Wei, Zeng, Zhifen, Liang, Yanran, Wu, Xia, Xiao, Songhua, Liu, Jun, Yang, Lianhong, Tao, Enxiang · 2014 · PLoS ONE
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
Cosma-Grigorov, Alexandra, Meixner, Holger, Mrochen, Anne, Wirtz, Stefan, Winkler, Jürgen, Marxreiter, Franz · 2020 · Frontiers in Neurology
The Role of the Western Diet and Oral Microbiota in Parkinson’s Disease
Barbara Zapała, Tomasz Stefura, Tomasz Milewicz, Julia Wątor, Monika Weronika Piwowar, Magdalena Wójcik-Pędziwiatr, Magdalena Doręgowska, Alicja Dudek, Zuzanna Jania, Monika Rudzińska · 2022 · Nutrients
Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions
Kumar, Vinod, Singh, Brajesh Kumar, Chauhan, Amit Kumar, Singh, Deepali, Patel, Devendra Kumar, Singh, Chetna · 2016 · Molecular Neurobiology
Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model
Sun, Congcong, Wang, Yun, Mo, Mingshu, Song, Chengyuan, Wang, Xingbang, Chen, Si, Liu, Yiming · 2019 · BioMed Research International
Gut Microbiota and Metabolome Distinctive Features in Parkinson Disease: Focus on Levodopa and Levodopa-carbidopa Intrajejunal Gel
Melis, Marta, Vascellari, Sarah, Santoru, Maria Laura, Oppo, Valentina, Fabbri, Margherita, Sarchioto, Marianna, Murgia, Daniela, Zibetti, Maurizio, Lopiano, Leonardo, Serra, Alessandra et al. · 2021 · European Journal of Neurology
The Gut Microbiota Metabolite Propionate Ameliorates Intestinal Epithelial Barrier Dysfunction-Mediated Parkinson’s Disease via the AKT Signaling Pathway
Huang, Tingting, Shi, Hongjuan, Xu, Yuanfeng, Ji, Lili · 2021 · Neuroreport
Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease
Markulin, Iva, Matasin, Marija, Turk, Viktorija Erdeljic, Salković-Petrisic, Melita · 2022 · Journal of Neural Transmission
TREGking From Gut to Brain: The Control of Regulatory T Cells Along the Gut-Brain Axis
Juli Choi, Boram Kim, Begum Akuzum, Leechung Chang, June‐Yong Lee, Ho‐Keun Kwon · 2022 · Frontiers in Immunology
Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease
Subramanian Thangaleela, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Muruganantham Bharathi, Chaiyavat Chaiyasut · 2022 · Microorganisms
The Protective Effect of Minocycline in a Paraquat-Induced Parkinson's Disease Model in Drosophila is Modified in Altered Genetic Backgrounds
Arati A. Inamdar, Anathbandhu Chaudhuri, Janis M. O’Donnell · 2012 · Parkinson s Disease
Ceftriaxone Reverses Deficits of Behavior and Neurogenesis in an MPTP-Induced Rat Model of Parkinson’s Disease Dementia
Hsieh, Ming-Hong, Meng, Wan-Yun, Liao, Wen-Chieh, Weng, Jun-Cheng, Li, Hsin-Hua, Su, Hong-Lin, Lin, Chih-Li, Hung, Ching-Sui, Ho, Ying-Jui · 2017 · Brain Research Bulletin
A Novel Pathway for Microbial Metabolism of Levodopa
Jameson, K. G., Hsiao, E. Y. · 2019 · Nature Medicine
Leaky Gut, Dysbiosis, and Enteric Glia Activation: The Trilogy behind the Intestinal Origin of Parkinson’s Disease
Seguella, Luisa, Sarnelli, Giovanni, Esposito, Giuseppe · 2020 · Neural Regeneration Research
Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics
Gábor Ternák, Dániel Kuti, Krisztina Kovács · 2020 · Medical Hypotheses
LPS-Binding Protein Mediates LPS-Induced Liver Injury and Mortality in the Setting of Biliary Obstruction
Minter, Rebecca M., Bi, Xiaoming, Ben-Josef, Gal, Wang, Tianyi, Hu, Bin, Arbabi, Saman, Hemmila, Mark R., Wang, Stewart C., Remick, Daniel G., Su, Grace L. · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
A New Avenue for Treating Neuronal Diseases: Ceftriaxone, an Old Antibiotic Demonstrating Behavioral Neuronal Effects
Tai, Chun-Hwei, Bellesi, Michele, Chen, An-Chih, Lin, Chih-Li, Li, Hsin-Hua, Lin, Pin-Jiun, Liao, Wen-Chieh, Hung, Ching-Sui, Schwarting, Rainer K., Ho, Ying-Jui · 2019 · Behavioural Brain Research
Dietary Intake of Parkinson's Disease Patients
Florence Baert, Christophe Matthys, Randy Mellaerts, Dirk Lemaître, Geertrui Vlaemynck, Veerle Foulon · 2020 · Frontiers in Nutrition
Gut Microbiota Relieves Inflammation in the Substantia Nigra of Chronic Parkinson’s Disease by Protecting the Function of Dopamine Neurons
Zhang, Tian, Wang, Tan, Chen, Xinxu, Zhao, Zhenqiang, Chen, Zhibin · 2021 · Experimental and Therapeutic Medicine
Gut Bacterial Tyrosine Decarboxylase Associates with Clinical Variables in a Longitudinal Cohort Study of Parkinsons Disease
van Kessel, Sebastiaan P., Auvinen, Petri, Scheperjans, Filip, El Aidy, Sahar · 2021 · npj Parkinson s Disease
Rifampicin Attenuates Rotenone-Treated Microglia Inflammation via Improving Lysosomal Function
Liang, Yanran, Zheng, Dezhi, Peng, Sudan, Lin, Danyu, Jing, Xiuna, Zeng, Zhifen, Chen, Ying, Huang, Kaixun, Xie, Yingyu, Zhou, Tianen et al. · 2020 · Toxicology in Vitro
β-hydroxybutyrate (β-HB) exerts anti-inflammatory and antioxidant effects in lipopolysaccharide (LPS)-stimulated macrophages in Liza haematocheila
Guo Qiao, Tingli Lv, Mingming Zhang, Peng Chen, Qirui Sun, Jialin Zhang, Qiang Li · 2020 · Fish & Shellfish Immunology
A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer’s disease
Ayuni Yussof, Paul Yoon, Cayley Krkljes, Sarah Schweinberg, Jessica Ann Cottrell, Tin-Chun Chu, Sulie L. Chang · 2020 · Scientific Reports
Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by <scp>l</scp>‐DOPA in hemiparkinsonian rats
Bortolanza, Mariza, do Nascimento, Glauce C., Raisman‐Vozari, Rita, Del‐Bel, Elaine · 2021 · British Journal of Pharmacology
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
Jade E. Kenna, Eng Guan Chua, Megan C. Bakeberg, Chin Yen Tay, Sarah McGregor, Anastazja M. Gorecki, Malcolm Kenneth Horne, Barry James Marshall, Frank Louis Mastaglia, Ryan S. Anderton · 2021 · Frontiers in Neuroscience
Mind the gut: secretion of α‐synuclein by enteric neurons
Stefan A. Grathwohl, Jennifer A. Steiner, Markus Britschgi, Patrik Brundin · 2013 · Journal of Neurochemistry
Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
Stefania Kalampokini, Anouck Becker, Klaus C Fassbender, Epameinondas Lyros, Marcus Michael Unger · 2019 · Parkinson s Disease
Diet, Gut Microbiome, and Cognitive Decline
Susan E. Ettinger · 2022 · Current Nutrition Reports
Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
Marthinus Janse van Vuuren, Theo A. Nell, Jonathan Ambrose Carr, Douglas Bruce Kell, Etheresia Pretorius · 2020 · Biomolecules
Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
Natalia Palacios, Anas Hannoun, Julie Flahive, Doyle V. Ward, Kelsey J. Goostrey, Anindita Deb, Kara M. Smith · 2021 · Frontiers in Neurology
Minocycline Protects Dopaminergic Neurons Against Long-Term Rotenone Toxicity
Radad, Khaled, Moldzio, Rudolf, Rausch, Wolf-Dieter · 2010 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury
Emilie Cornille, Mhamad Abou-Hamdan, Michel Khrestchatisky, André L. Nieoullon, Max L. De Reggi, Bouchra Gharib · 2010 · BMC Neuroscience
The Effects of the β-Lactam Antibiotic, Ceftriaxone, on Forepaw Stepping and l-DOPA-Induced Dyskinesia in a Rodent Model of Parkinson’s Disease
Kelsey, John E., Neville, Caroline · 2014 · Psychopharmacology
Dual role of the nasal microbiota in neurological diseases—An unignorable risk factor or a potential therapy carrier
Jin Xie, Shimin Tian, Jun Liu, Ruiyi Cao, Pengfei Yue, Xinfu Cai, Qiang Shang, Ming Hui Yang, Li Han, Dingkun Zhang · 2022 · Pharmacological Research
Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson’s disease patients for the identification and validation of biomarkers for Parkinson’s disease subtypes, progression and pathophysiology
Jeffrey M. Boertien, Sygrid van der Zee, Asterios Chrysou, Marleen J. J. Gerritsen, Nomdo M. Jansonius, Jacoba Margje Spikman, Teus van Laar, the PPNN Study Group, N. A. Verwey, Barbera van Harten et al. · 2020 · BMC Neurology
Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson’s Disease
Adela Dănău, Laura Dumitrescu, Antonia Lefter, Delia Tulbă, Bogdan Ovidiu Popescu · 2021 · International Journal of Molecular Sciences
Altered Gut Microbiota in Parkinson’s Disease Patients with Motor Complications
Takahashi, Kai, Nishiwaki, Hiroshi, Ito, Mikako, Iwaoka, Kazuhiro, Takahashi, Kenta, Suzuki, Yoshio, Taguchi, Keita, Yamahara, Kanako, Tsuboi, Yoshio, Kashihara, Kenichi et al. · 2022 · Parkinsonism & Related Disorders
Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson’s disease dementia
Chiu-Ku Huang, Yen‐Ting Chang, Tamara G. Amstislavskaya, Maria A. Tikhonova, Chih‐Li Lin, Ching‐Sui Hung, Te‐Jen Lai, Ying‐Jui Ho · 2015 · Behavioural Brain Research
Gene–Dairy Food Interactions and Health Outcomes: A Review of Nutrigenetic Studies
Kevin B. Comerford, Gonca Pasin · 2017 · Nutrients
Deep Nasal Sinus Cavity Microbiota Dysbiosis in Parkinson’s Disease
Pal, Gian, Ramirez, Vivian, Engen, Phillip A., Naqib, Ankur, Forsyth, Christopher B., Green, Stefan J., Mahdavinia, Mahboobeh, Batra, Pete S., Tajudeen, Bobby A., Keshavarzian, Ali · 2021 · npj Parkinson s Disease
Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects
Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree · 2018 · Current Treatment Options in Gastroenterology
Development of a Novel Oral Delivery Vehicle for Probiotics
Kevin Enck, Surya R. Banks, Hariom Yadav, Mark E. Welker, Emmanuel C. Opara · 2020 · Current Pharmaceutical Design
The Need for Personalized Approaches to Microbiome Modulation
Nita Jain · 2020 · Frontiers in Public Health
Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease
Aeja Jackson, Phillip A. Engen, Christopher B. Forsyth, Maliha W. Shaikh, Ankur D Naqib, Sherry Wilber, Dulce M. Frausto, Shohreh Raeisi, Stefan J. Green, Brinda Desai Bradaric et al. · 2022 · Frontiers in Neurology
Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
Dominika Fričová, Jana Harsányiová, Alzbeta Kralova Trancikova · 2020 · International Journal of Molecular Sciences
Effects of a Ketogenic Diet on Symptoms, Biomarkers, Depression, and Anxiety in Parkinson’s Disease: A Case Study
Melanie M. Tidman · 2022 · Cureus
Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
Michal Lubomski, Xiangnan Xu, Andrew J. Holmes, Samuel Müller, Jean Yee Hwa Yang, Ryan L. Davis, Carolyn M. Sue · 2022 · Frontiers in Aging Neuroscience
The relationship between Parkinson’s disease and gastrointestinal diseases
Jiaqi Zeng, Xinchan Wang, Fei Pan, Zhiqi Mao · 2022 · Frontiers in Aging Neuroscience
Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth
María Ángeles Martín, Iñaki Robles‐Vera, A Sánchez-Roncero, Fernando Escrivá, Francisco Pérez‐Vizcaíno, Juan Duarte, Carmen Álvarez, Elisa Fernández‐Millán · 2020 · The Journal of Nutritional Biochemistry
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease
Xiaoqin He, Yiwei Qian, Shaoqing Xu, Yi Zhang, Chengjun Mo, Wentian Guo, Xiaodong Yang, Qin Xiao · 2021 · Journal of Parkinson s Disease
Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
Drobny, Alice, Ngo, Phuong A., Neurath, Markus F., Zunke, Friederike, López-Posadas, Rocío · 2021 · Frontiers in Medicine
Lack of Effect of Ceftriaxone, a GLT-1 Transporter Activator, on Spatial Memory in Mice
Karaman, Ipek, Kizilay-Ozfidan, Gulnur, Karadag, C. Hakan, Ulugol, Ahmet · 2013 · Pharmacology Biochemistry and Behavior
Rifampicin pre-treatment inhibits the toxicity of rotenone-induced PC12 cells by enhancing sumoylation modification of α-synuclein
Daowei Lin, X. Jing, Y. Chen, Yuxia Liang, Ming Lei, Sheng Peng, Teng Zhou, D. Zheng, Z. Zeng, Xia Wu et al. · 2017 · Biochemical and Biophysical Research Communications
Alterations in Neuronal Survival and Glial Reactions after Axotomy by Ceftriaxone and Minocycline in the Mouse Hypoglossal Nucleus
Yamada, Jun, Jinno, Shozo · 2011 · Neuroscience Letters
A study on the protective role of doxycycline upon dopaminergic neuron of LPS-PD rat model rat.
Zhang Gb, Feng Yh, Wang Pq, Song Jh, P Wang, S-A Wang · 2015 · PubMed
Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease
Daniel Grúň, Valerie C. Zimmer, Jil Kauffmann, Jörg Spiegel, Ulrich Dillmann, Andreas Schwiertz, Klaus C Fassbender, Mathias Fousse, Marcus Michael Unger · 2019 · Parkinsonism & Related Disorders
Fecal microbiota transfer for bowel disorders: efficacy or hype?
Max Julio Schmulson, Mohammad Bashashati · 2018 · Current Opinion in Pharmacology
Minocycline Inhibits ICAD Degradation and the NF-ΚB Activation Induced by 6-OHDA in PC12 Cells
Jiang, Bao-Ping, Le, Liang, Xu, Li-Jia, Xiao, Pei-Gen · 2014 · Brain Research
Minocycline May Be Useful to Prevent/Treat Postoperative Cognitive Decline in Elderly Patients
Fan, L., Wang, Tian-Long, Xu, Y.C., Ma, Y.H., Ye, W.G. · 2011 · Medical Hypotheses
Weight Loss in Parkinson’s Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth
John K. DiBaise, Michael D. Crowell, Erika D. Driver‐Dunckley, Shyamal H. Mehta, Charlene Hoffman‐Snyder, Tanya P. Lin, Charles H. Adler · 2018 · Journal of Parkinson s Disease
Gastrointestinal Non-Motor Dysfunction in Parkinson’s Disease Model Rats with 6-hydroxydopamine
Xiao‐Yan Feng, Jingting Yan, Xiaoli Zhang, Jin‐Xia Zhu · 2019 · Physiological Research
Host genetics influence the gut microbiome
Liliana Cortés‐Ortiz, Katherine Ryan Amato · 2021 · Science
Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain
Guo, Xingzhi, Tang, Peng, Hou, Chen, Chong, Li, Zhang, Xin, Liu, Peng, Chen, Li, Liu, Yue, Zhang, Lina, Li, Rui · 2022 · Frontiers in Microbiology
The antibiotic doxycycline mimics the NGF signaling in PC12 cells: A relevant mechanism for neuroprotection
Amaral, Lilian do, Santos, Neife Aparecida Guinaim dos, Sisti, Flávia Malvestio, Del Bel, Elaine, Santos, Antônio Cardozo dos · 2021 · Chemico-Biological Interactions
Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
José Fidel Baizabal‐Carvallo, Marlene Alonso‐Juarez, Róbert Fekete · 2021 · Frontiers in Neurology
Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease
Rocco Cerroni, Daniele Pietrucci, Adelaide Teofani, Giovanni Chillemi, Claudio Liguori, Mariangela Pierantozzi, Valeria Unida, Sidorela Selmani, Nicola Biagio Mercuri, Alessandro Stefani · 2022 · Brain Sciences
Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters
Gerhard N. Ransmayr, Werner H Poewe, S. Pl�rer, F Gerstenbrand, Karl Leidlmair, U. Mayr · 1986 · Journal of Neural Transmission
Minocycline Inhibition of Microglial Rescues Nigrostriatal Dopaminergic Neurodegeneration Caused by Mutant Alpha-Synuclein Overexpression
Wang, Yong, Wang, Qian, Yu, Ruobing, Zhang, Qi, Zhang, Zhonghai, Li, Haiying, Ren, Chao, Yang, Rongli, Niu, Haichen · 2020 · Aging
Leveraging Sequence-based Faecal Microbial Community Survey Data to Identify Alterations in Gut Microbiota among Patients with Parkinson’s Disease
Ji, Tianyi, Huang, Hongyan, Liu, Jiaxuan, Peng, Tian, Zhou, Xiazhu, Tan, Qin, Yuan, Jiaguo, Hua, Huan, Ding, Songtao, Liu, Handeng · 2021 · European Journal of Neuroscience
Dietary Patterns and Nonmotor Symptoms in Parkinson’s Disease: A Cross-Sectional Analysis
Sophie Lawrie, Shelly Coe, Maedeh Mansoubi, Jessica Welch, Jamil Razzaque, Michele T. Hu, Helen Dawes · 2022 · Journal of the American Nutrition Association
Frailty and cognitive impairment in Parkinson’s disease: a systematic review
M. C. Sousa-Fraguas, Gustavo Rodríguez Fuentes, Nélida M. Conejo · 2022 · Neurological Sciences
Gut Microbiota in Monozygotic Twins Discordant for Parkinson's Disease
Carlotta Bolliri, Alessandra Fontana, Emanuele Cereda, Michela Barichella, Roberto Cilia, Valentina Ferri, Serena Caronni, Daniela Calandrella, Lorenzo Morelli, Gianni Pezzoli · 2022 · Annals of Neurology
Induction of Parkinsonian-Like Changes via Targeted Downregulation of Astrocytic Glutamate Transporter GLT-1 in the Striatum
Chao Ren, Kai-Jie He, Hua Hu, Jin-Bao Zhang, Li-Guo Dong, Dan Li, Jing Chen, Cheng-Jie Mao, Fen Wang, Chun-Feng Liu · 2021 · Journal of Parkinson s Disease
A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
Shih‐Chen Fu, Chung‐Han Lee, Yi‐Chen Hsieh, Pei-Hua Wu, Sheng‐Hsuan Lin, Hsiuying Wang · 2022 · Frontiers in Cellular and Infection Microbiology
Potential of Antibiotics for the Treatment and Management of Parkinson's Disease: An Overview
Narayan Yadav, Ajit Kumar Thakur, Nikhila Shekhar, AYUSHI . · 2021 · Current Drug Research Reviews
Editorial: Common Pathways Linking Neurodegenerative Diseases—The Role of Inflammation
Małgorzata Kujawska, Andrii Domanskyi, Grzegorz Kreiner · 2021 · Frontiers in Cellular Neuroscience
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen · 2022 · European Journal of Inflammation
Gut Microbes and Neuropathology: Is There a Causal Nexus?
Katherine Dinan, Timothy G. Dinan · 2022 · Pathogens
Parkinson disease, levodopa and the gut microbiota—when microbiology meets pharmacology
Harald Brüssow · 2020 · Environmental Microbiology
Feeding Our Microbiota: Stimulation of the Immune/Semiochemical System and the Potential Amelioration of Non-Communicable Diseases
David A. Smith, Sohan Jheeta, Hannya V. Fuentes, Miryam Palacios-Pérez · 2022 · Life
Drug Metabolism as a Community Effort
Hitchings, Reese, Kelly, Libusha · 2019 · Cell Metabolism
Long-Term Use of Antibiotics and Risk of Parkinson’s Disease in the Nurses’ Health Study
Natalia Palacios, Éilis J. O’Reilly, Michael A. Schwarzschild, Alberto Ascherio · 2020 · Parkinson s Disease
Rifaximin modulates TRH and TRH-like peptide expression throughout the brain and peripheral tissues of male rats
Albert Eugene Pekary, Albert Sattin · 2022 · BMC Neuroscience
Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline
Department of Physiology, Physiological Research Center, Iran University of Medical Sciences, Tehran, Iran., Maneshian, Marzieh, Nasirinezhad, Farinaz, Department of Physiology, Physiological Research Center, Iran University of Medical Sciences, Tehran, Iran., Mohammadi, Fatemeh, Intracellular Recording Lab, Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Behzadi, Mina, Intracellular Recording Lab, Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran., Asadi-Shekaari, Majid, Intracellular Recording Lab, Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran. et al. · 2021 · Basic and Clinical Neuroscience Journal
Antibiotics for neurological ailments?
Adrian Burton · 2005 · The Lancet Neurology